시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
희귀질환 치료 시장 규모, 점유율, 성장 분석 : 치료 영역별, 약물 유형별, 투여 경로별, 환자 유형별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)
Rare Disease Treatment Market Size, Share, and Growth Analysis, By Therapeutic Area, By Drug Type, By Route of Administration, By Patient Type, By Distribution Channel, By Region - Industry Forecast 2025-2032
상품코드 : 1663005
리서치사 : SkyQuest Technology Consulting Pvt. Ltd.
발행일 : 2025년 02월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,465,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,732,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,000,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 희귀질환 치료 시장 규모는 2023년에 1,949억 3,000만 달러로 평가되며, 2024년 2,138억 4,000만 달러에서 2032년에는 4,484억 8,000만 달러로 성장하며, 예측 기간 중(2025-2032년) CAGR은 9.7%로 성장할 전망입니다.

희귀질환 치료제 시장은 개별적으로는 희귀하지만 전 세계 수백만 명에게 영향을 미치는 희귀질환을 치료함으로써 제약산업에서 중요한 역할을 하고 있습니다. 이 시장은 인식의 향상, 유전자 연구의 발전, 혁신적인 치료 전략, 특히 정밀의료의 발전으로 성장하고 있습니다. 유전체학의 발전으로 환자별 유전자 프로파일에 맞는 표적 치료가 가능해졌습니다. 또한 희귀질환 치료제 지정과 같은 지원적인 규제 프레임워크가 제약사의 투자를 촉진하고 있습니다. 학계, 연구기관, 환자 지원 단체의 협력 체계는 연구와 임상시험을 더욱 촉진하고 있습니다. 그럼에도 불구하고 높은 개발 비용과 임상시험 참여자 모집과 같은 장애물이 존재합니다. 이러한 장애물에도 불구하고 시장은 확대될 태세를 보이고 있으며, 그동안 소외되었던 질병에 대한 혁신적인 치료법이 기대되고 있습니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

희귀질환 치료 시장 규모 : 치료 영역별

희귀질환 치료 시장 규모 : 약물 유형별

희귀질환 치료 시장 규모 : 투여 경로별

희귀질환 치료 시장 규모 : 환자 유형별

희귀질환 치료 시장 규모 : 유통 채널별

희귀질환 치료 시장 규모

경쟁 정보

주요 기업 개요

결론과 제안

KSA
영문 목차

영문목차

Global Rare Disease Treatment Market size was valued at USD 194.93 billion in 2023 and is poised to grow from USD 213.84 billion in 2024 to USD 448.48 billion by 2032, growing at a CAGR of 9.7% during the forecast period (2025-2032).

The rare disease treatment market plays a vital role in the pharmaceutical industry by addressing orphan diseases that, while individually rare, collectively impact millions globally. The market is experiencing growth fueled by heightened awareness, advancements in genetic research, and innovative therapeutic strategies, particularly through precision medicine. Breakthroughs in genomics allow for targeted therapies that cater to the unique genetic profiles of patients. Additionally, supportive regulatory frameworks, such as orphan drug designations, encourage investment from pharmaceuticals. Collaborative efforts among academia, research institutions, and patient advocacy organizations further expedite research and clinical trials. Nevertheless, challenges such as high development costs and recruitment in clinical trials pose obstacles. Despite these hurdles, the market is poised for expansion, promising transformative therapies for neglected conditions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Rare Disease Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Rare Disease Treatment Market Segments Analysis

Global Rare Disease Treatment Market is segmented by Therapeutic Area, Drug Type, Route of Administration, Patient Type, Distribution Channel and region. Based on Therapeutic Area, the market is segmented into Cancer, Musculoskeletal Conditions, Respiratory Disorders, Cardiovascular Disorders, Neurological Disorders, Hematology, Infectious Diseases and Metabolic Disorders. Based on Drug Type, the market is segmented into Biologics and Non-biologics. Based on Route of Administration, the market is segmented into Oral, Injectable and Others. Based on Patient Type, the market is segmented into Adult and Pediatric. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Rare Disease Treatment Market

A significant factor fueling the Global Rare Disease Treatment market is the increasing investment in research and development aimed at creating innovative therapies for rare diseases. This surge in funding is paving the way for breakthroughs in biotechnology, genomics, and personalized medicine, which are key to unearthing new and effective treatment options. As scientists and researchers harness these advancements, they are not only enhancing our understanding of rare diseases but also facilitating the development of targeted therapies that can significantly improve patient outcomes. This concerted effort underscores the commitment to addressing the unmet medical needs of those affected by rare conditions.

Restraints in the Global Rare Disease Treatment Market

One of the primary challenges facing the Global Rare Disease Treatment market is the substantial financial burden associated with research, clinical trials, and the development of therapies for these conditions. The relatively small patient population complicates the ability to recuperate the high expenses involved, which in turn contributes to elevated drug prices. Consequently, this economic barrier can impede investment in new treatments and limit the availability of affordable options for patients suffering from rare diseases. As a result, the high costs associated with developing effective therapies represent a considerable restraint within the market.

Market Trends of the Global Rare Disease Treatment Market

The Global Rare Disease Treatment market is experiencing a significant trend towards advancements in precision medicine, which is revolutionizing how rare diseases are identified and treated. This evolution allows for the creation of targeted therapies designed to address specific genetic mutations or molecular abnormalities, thereby enhancing treatment efficacy and minimizing adverse effects. As personalized medicine gains traction, stakeholders are increasingly investing in research and development to harness the potential of genetic insights and biomarkers. Such innovations not only promise improved patient outcomes but also ensure a more cost-effective treatment landscape, positioning precision medicine as a cornerstone of future rare disease management strategies.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Rare Disease Treatment Market Size by Therapeutic Area & CAGR (2025-2032)

Global Rare Disease Treatment Market Size by Drug Type & CAGR (2025-2032)

Global Rare Disease Treatment Market Size by Route of Administration & CAGR (2025-2032)

Global Rare Disease Treatment Market Size by Patient Type & CAGR (2025-2032)

Global Rare Disease Treatment Market Size by Distribution Channel & CAGR (2025-2032)

Global Rare Disease Treatment Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기